Based on the recent evidence, FGF21 might be a new effective method for the treatment of ALI (60), and further studies are required to investigate the underlying mechanisms and explore the potential clinical use of FGF21 for lung disease in the future. This evidence concerns the gene FGF21 and acute respiratory distress syndrome.